Inovio Pharmaceuticals, Inc. SEC filings INO
Inovio Pharmaceuticals, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Feb 20, 2008. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| FWP | Free writing prospectus | Nov 6, 2026 | — |
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Jul 30, 2026 | — |
| 424B5 | Prospectus supplement | Jul 29, 2026 | — |
| S-3 | Shelf registration | Jul 2, 2026 | — |
| S-8 | Employee stock plan registration | May 26, 2026 | — |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| 424B5 | Prospectus supplement | Jan 27, 2026 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Jul 3, 2025 | — |
| 424B5 | Prospectus supplement | Jul 2, 2025 | — |
| 424B5 | Prospectus supplement | Dec 13, 2024 | — |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| 424B5 | Prospectus supplement | Aug 13, 2024 | — |
| 424B5 | Prospectus supplement | Apr 17, 2024 | — |
| S-3/A | Filing | Jan 26, 2024 | — |
| S-3 | Shelf registration | Nov 9, 2023 | — |
| S-8 | Employee stock plan registration | May 18, 2023 | — |
| S-8 | Employee stock plan registration | May 18, 2023 | — |
| POS AM | Filing | Mar 1, 2023 | — |
| S-8 | Employee stock plan registration | Jun 30, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| 424B5 | Prospectus supplement | Nov 9, 2021 | — |
| S-8 | Employee stock plan registration | Mar 1, 2021 | — |
| 424B5 | Prospectus supplement | Jan 22, 2021 | — |
| 424B5 | Prospectus supplement | Jan 20, 2021 | — |
| S-3ASR | Automatic shelf registration | Jan 20, 2021 | — |
| 424B5 | Prospectus supplement | May 12, 2020 | — |
| 424B5 | Prospectus supplement | Apr 3, 2020 | — |
| S-3 | Shelf registration | Mar 13, 2020 | — |
| 424B5 | Prospectus supplement | Mar 9, 2020 | — |
| 424B5 | Prospectus supplement | Feb 7, 2020 | — |
| S-3 | Shelf registration | Jan 31, 2020 | — |
| S-8 | Employee stock plan registration | Jan 31, 2020 | — |
| S-8 | Employee stock plan registration | May 31, 2019 | — |
| S-8 | Employee stock plan registration | Mar 15, 2019 | — |
| 424B5 | Prospectus supplement | Jun 11, 2018 | — |
| S-3 | Shelf registration | May 25, 2018 | — |
| S-8 | Employee stock plan registration | Mar 19, 2018 | — |
| 424B5 | Prospectus supplement | Jul 20, 2017 | — |
| 424B5 | Prospectus supplement | Jul 18, 2017 | — |
| S-8 | Employee stock plan registration | Feb 14, 2017 | — |
| S-8 | Employee stock plan registration | Feb 14, 2017 | — |
| 424B5 | Prospectus supplement | Jun 17, 2016 | — |
| S-8 | Employee stock plan registration | Jan 28, 2016 | — |
| S-3 | Shelf registration | May 22, 2015 | — |
| 424B5 | Prospectus supplement | Apr 30, 2015 | — |
| 424B5 | Prospectus supplement | Apr 29, 2015 | — |
| S-3/A | Amendment #1 to form s-3 | Aug 6, 2014 | — |
| S-3 | Shelf registration | Jul 23, 2014 | — |
| S-8 | Employee stock plan registration | May 28, 2014 | — |
| 424B5 | Prospectus supplement | Feb 27, 2014 | — |
| 424B5 | Prospectus supplement | Feb 26, 2014 | — |
| S-3/A | Amendment no. 1 to form s-3 | Feb 11, 2014 | — |
| S-3 | Shelf registration | Jan 31, 2014 | — |
| S-8 | Employee stock plan registration | Nov 13, 2013 | — |
| 424B5 | Prospectus supplement | Mar 7, 2013 | — |
| 424B5 | Prospectus supplement | Mar 7, 2013 | — |
| 424B5 | Prospectus supplement | Jun 1, 2012 | — |
| S-8 | Employee stock plan registration | May 18, 2012 | — |
| 424B5 | Prospectus supplement | Dec 1, 2011 | — |
| 424B5 | Prospectus supplement | Nov 30, 2011 | — |
| S-3 | Shelf registration | Sep 2, 2011 | — |
| S-8 | Employee stock plan registration | May 20, 2011 | — |
| 424B5 | Prospectus supplement | Jan 26, 2011 | — |
| 424B2 | Prospectus | Jan 10, 2011 | — |
| 424B2 | Prospectus | Nov 16, 2010 | — |
| 424B5 | Prospectus supplement | Sep 7, 2010 | — |
| 424B5 | Prospectus supplement | Aug 27, 2010 | — |
| S-8 | Employee stock plan registration | May 18, 2010 | — |
| S-8 | Employee stock plan registration | Aug 26, 2009 | — |
| 424B5 | Prospectus supplement | Jul 30, 2009 | — |
| 424B3 | Prospectus | Jul 2, 2009 | — |
| 424B3 | Prospectus | Jun 29, 2009 | — |
| S-3/A | Filing | Jun 29, 2009 | — |
| POS AM | Filing | Jun 19, 2009 | — |
| S-3 | Shelf registration | Jun 19, 2009 | — |
| S-8 POS | Filing | Jun 19, 2009 | — |
| S-3 | Shelf registration | Jun 19, 2009 | — |
| 424B3 | Prospectus | May 5, 2009 | — |
| 424B3 | Prospectus | May 1, 2009 | — |
| S-4/A | Filing | Apr 27, 2009 | — |
| S-4/A | Filing | Apr 2, 2009 | — |
| S-4/A | Filing | Jan 23, 2009 | — |
| S-4 | Registration for a merger or exchange | Dec 10, 2008 | — |
| S-8 | Employee stock plan registration | May 9, 2008 | — |
Showing 88 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plymouth Meeting, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1055726
- Former names
- INOVIO BIOMEDICAL CORP (until May 11, 2010); GENETRONICS BIOMEDICAL CORP (until Apr 1, 2005); GENETRONICS BIOMEDICAL LTD (until Aug 3, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.